AbCellera and Bruker Reach Global Settlement of Patent Litigation [Yahoo! Finance]
Bruker Corporation (BRKR)
Last bruker corporation earnings: 10/31 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.bruker.com/investors/default.aspx
Company Research
Source: Yahoo! Finance
patent license agreement with Bruker Corporation, resolving the patent litigation between the two companies globally. As part of the settlement, Bruker will pay AbCellera $36 million up front as well as future royalty payments on sales of Bruker's Beacon ® Optofluidic platform products worldwide through the life of the licensed patents. About AbCellera Biologics Inc. AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women's health, immunology, and oncology. For more information, please visit www.abcellera.com AbCellera Forward-Looking Statements This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management's current beliefs and assumptions and on information currently available to management. All sta
Show less
Read more
Impact Snapshot
Event Time:
BRKR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BRKR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BRKR alerts
High impacting Bruker Corporation news events
Weekly update
A roundup of the hottest topics
BRKR
News
- Bruker (NASDAQ:BRKR) had its price target raised by analysts at JPMorgan Chase & Co. from $50.00 to $55.00. They now have an "overweight" rating on the stock.MarketBeat
- Bruker (NASDAQ:BRKR) had its price target raised by analysts at Bank of America Corporation from $43.00 to $60.00. They now have a "buy" rating on the stock.MarketBeat
- Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
- Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- Goldman Sachs Initiates Sell Rating On Bruker Corporation (BRKR) [Yahoo! Finance]Yahoo! Finance
BRKR
Earnings
- 11/3/25 - Beat
BRKR
Sec Filings
- 12/9/25 - Form 8-K
- 12/2/25 - Form 4
- 12/1/25 - Form 144
- BRKR's page on the SEC website